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Path of an RNA Ligand around the Surface
of the Vaccinia VP39 Subunit
of Its Cognate VP39-VP55 Protein Heterodimer
12], only one has yet been identified that is specifically
defective in PAP-processivity activity [12]; (3) no crystal
structure is available for VP55; and (4) VP39 shows no
significant sequence similarity to nonpoxvirus proteins.
For VP39’s 3 end-modifying function, the functionally
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Science Center relevant entity would be a ternary complex of VP55,
VP39, and the mRNA 3 end. A stable model ternaryHouston, Texas 77030
complex for the 3 end-modification reaction [13], con-
taining VP55, VP39, and a model polyadenylation-spe-
cific 50mer oligonucleotide ligand bearing the motifSummary
(rU)2-N25-rU (dubbed the “heterodimer binding motif”),
can be readily assembled. One macromolecular interac-VP39 is a vaccinia virus-encoded RNA modifying pro-
tein with roles in the modification of both mRNA ends. tion that undoubtedly occurs within this ternary complex
is the dimerization of VP39 and VP55. The VP39-VP55At the 3 end it acts as a processivity factor for the
vaccinia poly(A) polymerase (VP55), promoting poly(A) dimerization interface has previously been localized on
the surface of VP39 [12], circumventing the methodolog-tail elongation. Despite VP39’s three-dimensional
structure having been elucidated along with details ical hurdles described above through the use of various
molecular and biochemical approaches. Thus, sideof its mode of mRNA 5 end binding, the VP39-VP55
heterodimer’s molecular mechanism of processivity chains critical for dimerization, dimerization-dependent
steric effects, and distance constraints between the twois largely unknown. Here, the area immediately above
almost the entire surface of the VP39 subunit was subunits were identified via mutagenesis in combination
with a “pull-down” assay, protease footprinting, and aprobed using chemical reporters, and the path of a
previously unidentified RNA binding site was revealed. site-specific photocrosslinking assay, respectively; the
resulting data were modeled on the VP39 surface [12].The path was indicated to fall within a cleft formed
by the intersubunit interface and was consistent with In addition to the dimerization interface, one or both
subunits would be expected to interact with the oligonu-both a previously reported model of the heterodimer-
nucleic acid ternary complex and the known function cleotide component of the model ternary complex. Us-
ing a photosensitive analog located at position10 withof the heterodimer in processive poly(A) tail elon-
gation. respect to the oligonucleotide 3 end, a side chain of
VP39 has been identified that forms a zero-length photo-
crosslink with the downstream rU of the heterodimerIntroduction
binding motif of the oligonucleotide component [13].
This indicates that, within the ternary complex, VP39VP39 is a multifunctional vaccinia virus protein with roles
in the modification of both mRNA ends. At the 5 end it interacts directly with the 10 region. Moreover, the
location of the photocrosslinked side chain on the VP39acts catalytically as a cap-specific mRNA 2’-O-methyl-
transferase which converts the mRNA cap 0 structure surface indicated that VP39 possesses an RNA binding
site that is distinct from the crystallographically charac-(m7GpppN…) to its cap I (m7GpppNm…) counterpart [1,
2]. At the mRNA 3 end, VP39 apparently acts stoichio- terized cleft that docks with the capped mRNA 5 end.
Consistent with this, other studies have indicated themetrically, as a processivity factor for the vaccinia po-
ly(A) polymerase (PAP) VP55 [3], with which it forms a possession by VP39 of two distinct RNA binding sites,
only one of which shows cap specificity [14]. Thus, VP39heterodimer [4, 5]. VP39 may also have a third function,
namely, the control of transcript-length homeostasis, appears to possess distinct RNA binding sites for its 5
and 3 end mRNA-modifying functions, with the latterat the transcriptional level [6]. VP39’s high-resolution
crystal structure has been solved as a complex with its site lying close to, or within, the VP55-dimerization inter-
face [13]. It was not clear from these preliminary experi-methyltransferase cofactor (S-adenosyl methionine) and
ments whether the mRNA 3 end is completely enclosedwith cofactor-product (S-adenosyl homocysteine) plus
(“clamped”) within a “channel” running through the sub-5 capped RNA substrate [7–10]. Although these data
unit interface, or simply bound very close to one sidealong with supporting mutagenesis [8–11] have proven
of the interface.extremely informative with respect to VP39’s 5 end-
In addition to the above physical data, recent oligonu-modifying function, they have shed little or no light upon
cleotide selection and photocrosslinking studies haveVP39’s function at the mRNA 3 end, largely because
led to a conceptual model of the overall topology of a(1) mRNA 3 end-related nucleic acid ligands such as
VP55-VP39-model oligo ternary complex [15], whoseuncapped poly(A) have not been successfully cocrystal-
salient features are as follows: (1) the minimum oligonu-lized with VP39; (2) among the many tens or even hun-
cleotide size that stably binds the VP55-VP39 hetero-dreds of VP39 mutants that have been generated [2, 11,
dimer (45 – 50 nt) is 10 nt longer than that for monomeric
VP55 (35–40 nt) [13, 16]. This is because the presence1Correspondence: pgershon@tamu.edu
of VP39 “shifts” VP55s optimal (rU)2 contact point in2 Present address: Department of Tumor Biology, The Institute of
Medical Science, The University of Tokyo, Tokyo, Japan, 108-8639. the bound oligo from nucleotides26,27, with respect
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to the 3 end, to nucleotides 36, 37. Therefore, the series of spheres contacting one another close to the
VP39 surface with a minimum of intervening space. Tooptimized oligonucleotide ligands for VP55 and for the
heterodimer possess the motifs (rU)2-N15-rU and (rU)2- identify optimal cysteine positions, we took as a starting
point one of the two singly substituted cysteine mutantsN25-rU, respectively. (2) The 3 half of the heterodimer
binding motif-bearing oligonucleotide contacts both of [2] (we chose mutant C178S because in the other
mutant, C272S, the Cys178 side chain is almost entirelysubunits, apparently tracking close to the intersubunit
interface. (3) While the downstream rU of the hetero- buried and cannot be derivatized efficiently [12]) along
with the three single-cysteine mutants of Shi et al. [12]dimer binding motif (falling within the 3 half of the oligo-
nucleotide) contacts both VP39 and VP55, the upstream (R55C, R107C, F115C). From this starting point, the
above analysis (followed by a confirmation that the thiol(rU)2 portion contacts VP55 alone.
An overall understanding of the macromolecular con- of the cysteine substitution would be likely to be solvent
accessible), suggested that cysteine substitutions addi-tacts within the ternary complex would be of great value
in identifying the path of the mRNA 3 end across the tionally be made at residues F13, E29, P71, Y77, Y83,
K126, Q183, Y189, E217, N255, F265, and F293, and thatVP39 surface, the relationship between the mRNA 3
end binding site and the dimerization interface, and the mutant C272S was redundant. Figure 1A indicates the
patches of VP39’s water-impenetrable surface that arephysical reason for the 10 nt shift in VP55-oligonucleo-
tide contact point in the context of the heterodimer. enclosed by the 15 A˚ spheres, with each one shown as
a distinctly colored patch.Given the relatively long “minimum-length” of oligonu-
cleotide that is required for heterodimer binding (50 The sixteen mutants of the library (F13C, E29C, R55C,
P71C, Y77C, Y83C, R107C, F115C, K126C, C178S,nt, of which at least approximately the entire 3 half
apparently interacts with the VP39 subunit [15]), we felt Q183C, Y189C, E217C, N255C, F265C, and F293C) were
individually expressed in E. coli, and the recombinantthat an approach that addresses the entire subunit sur-
face was required. Since high-resolution structural ap- proteins were purified. The Coomassie-stained gel of
Figure 1B shows that each could be obtained in accept-proaches are still beyond reach for the ternary complex,
we have applied a site-specific photocrosslinking tech- able yield and purity. In the electrophoretic mobility shift
assay (EMSA, Figure 1C), each of the 16 mutants wasnique that was successfully used in the identification of
the VP55-VP39 dimerization interface [12] (above), but able to form a ternary complex with VP55 plus a 50mer
oligonucleotide bearing the (rU)2-N25-rU heterodimeron a more comprehensive scale. A comprehensive sin-
gle-cysteine mutant library was generated and applied binding motif (the same oligo referred to as “UU(dC)25U”
in Figure 2B of ref. [13]). The ability of each mutant toin the generation of photocrosslinking data along with
additional site-specific assays. Taken as a whole, the form a complex with VP55 and oligonucleotide indicated
that none of the single-cysteine substitutions grosslydata revealed the path of an mRNA polyadenylylation-
related RNA binding site on the VP39 surface, enclosing affected VP39’s macromolecular binding properties.
the side chain previously shown to form a zero-length
photocrosslink with the heterodimer binding oligonucle-
Site Specific Photocrosslinking Assayotide ligand. Part or all of the newly characterized RNA
As an initial approach to exploring the topology of thebinding surface apparently lies within a cleft formed at
VP39-VP55-oligonucleotide ternary complex, we usedthe interface between VP39 and VP55, whose properties
a site-specific photocrosslinking assay to identify re-may account for VP39’s function as a processivity factor.
gions of VP39 that are proximal to VP55 within the VP55-Moreover, the path of the RNA over the VP39 subunit
VP39 binary complex. This assay, which was initiallyshows the potential to template a “kink” into the bound
formulated by the Ebright lab [17], was implemented asRNA, which might account for the 10 nt shift in VP55-
described in [12]. Thus, a 125I-labeled version of a site-RNA contact position in the context of heterodimer. The
specific photocrosslinker, S-[2-(4-Azidosalicylamido)data correlate well our published conceptual model of
ethylthio]-2-thiopyridine (AET), was attached to thethe ternary complex [15].
unique cysteine of each mutant by disulfide exchange
followed by assembly of the derivatized VP39 mutants
into binary complexes with VP55, brief UV irradiation ofResults
the complexes and SDS-PAGE. As found previously [11],
mutant C178S/272S could not be labeled with 125I-AET,Single Cysteine Mutants of VP39
Wild-type VP39 possesses two cysteine residues, lo- consistent with the absence of cysteines therein (data
not shown). In addition, treatment of 125I-AET-derivatizedcated at positions 178 and 272 in the linear sequence.
VP39’s 2’-O-methyltransferase and PAP processivity mutants with reducing agent led to a complete loss of
label (data not shown), confirming thiol-specificity in thefunctions are not affected by serine substitution of the
two cysteines either individually or together [2]. Using site of AET attachment. Figure 2A shows the data for
each mutant. A band corresponding to photocross-the doubly substituted (“cysteine-minus”) mutant
(C178S/272S) as a template, a number of additional sin- linked VP55-VP39 heterodimer has previously been
shown to form after mixing AET-derivatized versions ofgle-cysteine substitution mutants have been con-
structed [12]. At the outset of the current study, we either R55C, R107C, or C178S with VP55 followed by
UV irradiation [12]. Herein, an equivalent band was de-extended this process by designing a “library” of single-
cysteine substitution mutants. Each cysteine was tected for these three mutants and also for nine others
(see Figure 2A, lane 4, for each of the mutants; dataplaced at a position on the VP39 surface which, when
forming the center of a 15 A˚ radius sphere, led to a summarized in Table 1, column 2). As previously [12], the
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Figure 1. Design, Expression, and Functionality of the Single-Cysteine Mutant
(A) Views of VP39’s water-impenetrable surface, generated using the program GRASP [25], through which invisible 15 A˚ radius spheres have
been projected. Each sphere is centered upon one of the sixteen side chains that was substituted with cysteine in this study, and patches
of surface enclosed within the spheres have each been given a different (arbitrary) color. The dominant color within each of the overlapping
regions is also arbitrary. Numbers within each patch denote the surface residue upon which the sphere was centered (and which was
substituted with cysteine in this study). Upper two rows: rightward rotations about the y axis through 360 (right-most view on upper row
corresponding to VP39’s cleft face containing the methyltransferase catalytic center). Lower row: Left-most view corresponds with same on
upper row, second and third views are 90 rotations about x axis (downward and upward, respectively).
(B) Composited Coomassie-stained SDS-PAGE gels showing the sixteen single-cysteine mutants. After running this gel and prior to subsequent
experiments, protein amounts were normalized with respect to one another.
(C) EMSA gel showing ternary complex formation by each of the sixteen mutants and also by wild-type VP39 (i.e., VP39-C26, the fully
functional C-terminal truncation mutant after expression in E. coli as described [26]). “F” indicates the free oligo, “T” indicates the VP55-
VP39-oligo ternary complex. The complex was clearly distinguishable as ternary both from its relative mobility and insofar as neither free
VP55 nor free VP39 bind this probe with sufficient stability to be visible after nondenaturing gel electrophoresis ([13] and [14], respectively).
band identified as corresponding to photocrosslinked tion (more specifically, ternary complex-dependent pho-
tocrosslinking, since VP55 is one of the three definingsubunits was UV dependent (for UV-minus control, see
Figure 2A, lane 3 for each mutant), implicating AET’s components of this complex). A 2-fold or greater en-
hancement (above the gray area in Figure 2C) was con-photoreactive aryl azide moiety.
To assay for VP55-dependent VP39-oligonucleotide sidered to be significant. Such an enhancement was
observed for eight of the mutants (as summarized inphotocrosslinking, a distinct site-specific photocross-
linking assay was developed in which the 16 mutants Table 1, column 3). It is not known why ternary complex-
nonspecific crosslinking is high for some mutants; how-were first derivatized with unlabeled AET, then UV irradi-
ated in the presence of 32P-labeled oligo UU-(dC)25-U in ever, the previously well-characterized methyltransfer-
ase-specific “cleft” binding site for capped mRNA 5either the absence or presence of VP55 (Figure 2B).
For 14 of the 16 mutants, photocrosslinked adducts ends is known to have some weak activity in the binding
of uncapped RNA [14], which could lead to the covalentbetween VP39 and oligo UU-(dC)25-U were detected in
either the absence or presence of VP55 or both (Figure trapping of oligo during the photocrosslinking assay.
Of the six mutants with detectable photocrosslinking2B, lanes 4 and 6 for each mutant; data summarized in
Table 1, column 3). The assay shown in Figure 2B was activity that is not VP55-enhanced (E29C, P71C, F115C,
Y189C, E217C, and F265C), the former three are arrayedrepeated, and the photocrosslinked band was quanti-
tated for each mutant in each of the duplicate assays. around the cleft.
In Figure 3, the data of Figure 2 are projected ontoMean fold enhancements in VP39-oligo photocrosslink-
ing due to the presence of VP55 are plotted in Figure the VP39 surface. Evidently, the newly characterized
VP39-RNA proximal regions found within the ternary2C where, due to the log scale, positive values indicate
VP55-induced enhancement of ternary complex forma- complex form a previously uncharacterized, contiguous
Chemistry & Biology
682
RNA binding site running across one surface of VP39.
Being ternary complex specific, this site is presumed to
act in VP39’s PAP processivity function. A previously
mapped ternary complex-specific, RNA-contacting side
chain (R107 [13]) is enclosed within the newly character-
ized site. The new site appears to be entirely distinct
from either the crystallographically defined methyltrans-
ferase-specific cleft [9] or the symmetry-related contact
site for the 3-most base of the cocrystallized ligand
that occurs on the reverse face of VP39 from the cleft
[9]. Interestingly, the newly characterized RNA binding
site appears to either run through the center of, or be
straddled by, VP39’s dimerization interface for VP55.
versions of each of the VP39 single-cysteine mutants in the presence
or absence of VP55 and UV irradiation. The abundant band at the
bottom of each gel corresponds to the labeled VP39 mutant. Arrow-
heads indicate bands corresponding to 125I-labeled photocross-
linked VP39-VP55 heterodimer. Minor contaminating proteins in the
VP39 mutant preparations have become derivatized to a variable
extent. VP55 has also become derivatized in some experiments,
due to difficulties removing all of the unreacted 125I-AET after VP39
derivatization. However, specific photocrosslinking products were
clearly identifiable on the basis of both electrophoretic mobility and
the combination of experimental factors (UV light, other macromole-
cules present, as indicated by /). To support the validity of our
assignments, each of the controls described in [12] was repeated
here (data not shown). The approximate migration positions of
14C-labeled protein standards are indicated to the left of each panel.
The migration positions are approximate insofar as the figure is a
composite from more than one gel.
(B) VP39 mutants derivatized with unlabeled AET: photocrosslinking
to 32P-labeled oligonucleotide in the presence and absence of VP55.
Storage phosphorgrams of SDS-PAGE gels show site-specific pho-
tocrosslinking products for 32P-labeled oligo UU-(dC)25-U in the pres-
ence or absence of unlabeled AET-derivatized versions of each of
the VP39 single-cysteine mutants, VP55, and UV irradiation. The
abundant lower band in each gel corresponds to free oligo. The
approximate migration positions of 14C-labeled protein standards
are indicated to the left of each panel. The migration positions are
approximate insofar as the figure is a composite from several differ-
ent gels. For mutant Q183C, the electrophoretic mobility of the
crosslinked species corresponded exactly to that of other cross-
linked single-cysteine mutant samples run in the same gel (e.g., the
adjacent K126C samples), indicating that crosslinking of full-length
Q183 protein was detected as opposed to that of the 32 kDa
contaminant visible in Figure 1B.
(C) Band intensities in the storage phosphorgrams of (B) and a
duplicate experiment (data not shown) were quantitated, and mean
values were calculated for each mutant. The ordinate (factor by
which VP55 enhances VP39-oligo photocrosslinking [log]) indicates
log transformations of the mean intensity of the photocrosslinked
band in the presence of VP55 (lane 6 of panel [B] or replicate
experiment)/intensity of the photocrosslinked band in the absence
of VP55 (lane 4 of panel [B] or replicate experiment). Via the log
transformation, only mutants showing VP55 enhancement of photo-
crosslinking score positive, a value of “1” representing one order
of magnitude. Error bars denote the two individual values (only one
of the two error bars being visible in most cases). The horizontal
line at factor 2 (log10factor 0.3) represents the designated thresh-
old for significant ternary complex-specific photocrosslinking (the
area below this line is colored gray). For each of the positive-scoring
single-cysteine mutants, values for both of the two contributing
replicate experiments were above the threshold also. Where a pair
Figure 2. Photocrosslinking Data of closely spaced bands for the VP39-oligo photocrosslinked com-
(A) VP39 mutants derivatized with 125I-labeled AET: photocrosslink- plex in the absence of VP55 was clearly discernible and was con-
ing to VP55 within VP55-VP39(mutant) binary complexes. The com- verted to a single band in the presence of VP55 (e.g., for mutants
posite images of storage phosphorgrams of SDS-PAGE gels show Y77C, E217C, N255C, C178S, F293C, [B]), only the relevant member
site-specific photocrosslinking products for 125I-AET-derivatized of the pair contributed to the quantitation shown in (B).
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Table 1. Summary of Data Elucidated Herein
Crosslink VP55-Enhanced
to VP55 Crosslink to
(Figure Oligo (Figures Thiol Occlusion, VP55 Thiol Occlusion, VP55  oligo FeBABE
Mutant 2A) 2B and 2C) (Figures 4D–4F) (Figures 4D–4F) (Figure 5)
F13C N  
E29C    •
R55C • N  
P71C •    •
Y77C • H17009 U U
Y83C • H17009  
R107C • H17009  
F115C •   
K126C • H17009  
Q183C H17009  
Y189C •   
E217C •   
N255C • H17009  
F265C   
C178S(C272) • H17009  
F293C • H17009  
Crosslink to VP55 (column 2): •, UV-dependent VP55-dependent intersubunit photocrosslink detected. VP55-enhanced crosslink to oligo
(column 3): N, none detected; , unaffected by presence of VP55; H17009, significantly enhanced in presence of VP55, , diminished in presence
of VP55. Thiol occlusion (columns 4 and 5): U, unreactive; , unoccluded; , partially occluded; , occluded. FeBABE (column 6): •,
FeBABE-dependent oligo cleavage observed.
Thiol Occlusion Assay mutants (Y83C, R107C, N255C, F293C, Figures 4D–4F and
Table 1, column 5), the presence of oligo UU-(dC)25-U ledTo complement the photocrosslinking (proximity) data
(above), we aimed to identify surface regions of VP39 to a perceptible and reproducible decrease in reactivity
whose significance is unclear insofar as error bars repre-remaining accessible to solution-phase small molecules
after incorporating VP39 into the ternary complex. For sent maximum and minimum values from two experiments
only. Nonetheless, error bars in Figures 4D–4F are rela-this, we synthesized a thiol-specific Cy3 derivative (Cy3-
maleimide, Figure 4A). To check for specificity and reac- tively small despite representing minimum and maxi-
mum values, attesting to the reproducibility of the data.tivity, the compound was incubated with each of the 16
single-cysteine mutants and the cysteine-minus control We therefore feel it is notable that five of the six mutants
whose reactivity was perceived to drop in the presence(C178/272S), in the absence of other macromolecules,
followed by SDS-PAGE and fluorimaging (Figure 4B). of oligo UU-(dC)25-U (Y83C, R107C, F293C, C178S, and
N255C) comprise the complete set of mutants whoseThe cysteine-minus mutant (C178S/272S) did not react
detectably with Cy3-maleimide (Figure 4B), consistent unique thiols lie within the newly characterized RNA
binding site (Figure 6, below). The unique thiol of thewith its lack of a reactive thiol. With one exception
(Y77C), each of the single-cysteine mutants was clearly sixth mutant, P71C, lies close to the proposed “en-
trance” to the RNA binding site (see Discussion). Resultsreactive (Figure 4B) and was further investigated in a
reactivity timecourse assay. Reasons for the very low were therefore as one might expect to find for residues
at the interface of a protein-nucleic acid complex.reactivity of Y77C are unclear. As an example of the
timecourse assay, Figure 4C shows data for the reaction
of Cy3-maleimide with mutant F293C. Chemical Nuclease Assay
To identify regions of VP39 proximal to oligonucleotideFigures 4D–4F show timecourse assay data for each
of the reactive single-cysteine mutants, either alone, in UU-(dC)25-U within the ternary complex, we coupled a
chemical nuclease, iron (S)-1-(p-bromoacetamidoben-the presence of VP55, or in the presence of both VP55
and oligo UU-(dC)25-U. VP55 did not significantly affect zyl)-ethylenediaminetetraacetate (FeBABE), to each of the
sixteen single-cysteine mutants, followed by incubationCy3-maleimide access to the surface thiols of seven of
the reactive mutants (Figure 4D; Table 1, column 4). with VP55 and oligo UU-(dC)25-U (either 5 or 3 end-
labeled) in an attempt to form a ternary complex. Site-For three reactive mutants, an intermediate effect was
observed in which rates of access were significantly directed cleavage was initiated using ascorbate and hy-
drogen peroxide. The resulting hydroxyl radicals werediminished (Figure 4E, Table 1 column 4). Access of
Cy3-maleimide to the surface thiols of the remaining expected to be localized within a 10 A˚ radius of the iron
center [18] which, together with the 12 A˚ of tether lengthfive reactive mutants was strongly restricted in the pres-
ence of VP55 (Figure 4F; Table 1, column 4). for FeBABE, would provide a maximum cleavage radius
of22 A˚ from the cysteine sulfur (25 A˚ from the car-For mutants P71C and C178S, the presence of oligo
UU-(dC)25-U led to a significant decrease in thiol accessi- bon). In the first step of this assay, we derivatized the
VP39 single cysteine mutants with FeBABE. FeBABEbility (Figures 4D–4F; Table 1, column 5), in which signifi-
cance is defined as clearly nonoverlapping error bars derivatization was monitored in control experiments by
following the FeBABE coupling step with a Cy3-malei-between oligo and oligo reactions. For four additional
Chemistry & Biology
684
Figure 3. Data from Crosslinking Experiments
of Figure2/Table 1, Projected onto the Crystal-
lographically Defined Surface of VP39
The VP39 surface was rendered (spacefill) us-
ing the program RASMOL2 [27] with pdb file
1av6. Leftward 90 rotations are shown, prog-
ressing from VP39’s reverse face (A) which
was previously shown to possess strong di-
merization contacts [12] through the side face
(B) and front face (C). The m7GpppGpApA
portion of the cocrystallized hexameric meth-
yltransferase substrate RNA [9] and the
S-adenosylhomocysteine methyltransferase
cofactor product are shown in stick rendering
in (C). Green and red sticks represent m7Gppp
cap and GpApA portions of the RNA, respec-
tively; blue stick represents AdoHcy. Brown:
Surface atoms located within 15 A˚ radius
spheres centered upon the side chains of
those AET-derivatized single-cysteine mu-
tants able to photocrosslink with both VP55
and oligo. Yellow: Surface atoms located
within 15 A˚ radius spheres centered upon the
mutated side chains of single-cysteine mu-
tants that are AET photocrosslinkable to VP55
but not oligo. All other surface atoms are uncol-
ored (white). Yellow regions were rendered
after brown regions, so that areas which are
unable to photocrosslink to the oligo are
dominantly defined. Since the role of the 3D
structures is to indicate topological consider-
ations alone, the variability in crosslinking ef-
ficiency that is apparent in Figure 2 is not
indicated in the figure.
mide incubation step. In these experiments, FeBABE- respectively; Table 1, column 6). The specific cleavages
were at oligo positions17 to –28 for the two derivatizedderivatization followed by extensive dialysis to eliminate
free FeBABE completely blocked the subsequent cou- mutants. After quantization of the electropherograms
obtained for cys-minus, E29C and P71C (Figure 5A, B,pling of Cy3-maleimide to the VP39 mutants (data not
shown), indicating a high efficiency of FeBABE coupling. lanes 9, 10 and 10, 11), followed by subtraction of the
average quantized signal for the 14 negative mutantsIn other control experiments, each of the mutant pro-
teins could be derivatized with FeBABE as monitored (data not shown), cleavage nodes were clearly apparent
for E29C and P71C in contrast to cysteine-minus (plottedusing 55FeBABE [19]. However, after combining the
55FeBABE-labeled VP39 single-cysteine mutants with to the left of electropherograms, Figure 5). In control
incubations of oligo with FeBABE-underivatized cys-VP55 and oligo UU-(dC)25-U and subjecting the mixtures
to the EMSA, ternary complexes were found to be desta- teine-minus, E29C, or P71C, or derivatized versions in
the absence of ascorbate/peroxide, only uniform back-bilized by prior FeBABE derivatization of the mutant
proteins (data not shown). This may arise from the bulky ground levels of cleavage products were observed at
low abundance (Figures 5A and 5B, lanes 2–7 and 3–8,and ionic nature of the FeBABE reagent with respect
to other cysteine-derivatization reagents used herein, respectively), indicating that the observed nodes were
a result of specific chemical cleavage. Other controlsalong with its longer reach.
It was considered that, although sensitive to EMSA gel indicated an absence of cleavage activity associated
with VP55 (data not shown). Finally, the absence of spe-analysis, FeBABE-VP39/VP55/oligo ternary complexes
might be sufficiently stable to attempt chemical cleav- cific cleavage nodes upon omission of VP55 but in the
presence or absence of peroxide/ascorbate, (data notage analysis. Thus, FeBABE-derivatized VP39 single-
cysteine mutant proteins were mixed with oligo and shown) indicated that the cleavage nodes for E29C and
P71C were ternary complex specific.VP55 followed by incubation with peroxide and ascor-
bate, and electrophoresis of the oligonucleotide prod- The E29 and P71 mutation sites are positioned fairly
close to one another on the VP39 surface (Figure 6).ucts in polyacrylamide-urea gels. Specific signals were
observed for only 2 of the 16 mutants, namely, E29C Interestingly, despite the ability of FeBABE-derivatized
versions of mutants E29C and P71C to cleave oligoand P71C, and were observed using either 5 or 3 end-
labeled oligo (Figures 5A and 5B, lanes 9, 10 and 10, 11, UU-(dC)25-U within the ternary complex, AET-derivatized
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Figure 4. Development and Implementation of the Thiol-Occlusion Assay
(A–C) Development of the assay. (A) Molecular structure of Cy3-maleimide, as synthesized herein. (B) Fluorimage of SDS-PAGE gel showing
the reactivity of each of the sixteen single-cysteine mutants with Cy3-maleimide in the absence of other macromolecules. The migration
positions of protein standards are indicated to the left. “C178S/C272S” denotes the cysteine-minus mutant. Fluorescence for F13C, although
barely visible in the main panel, was visible upon increasing contrast (right panel). (C) Reactivity timecourse data for mutant F293C in the
absence of other macromolecules. Upper panel: Fluorimage of SDS-PAGE gel showing samples taken at various times (1–75 min) after mixing
mutant F293C with Cy3-maleimide in the presence/absence of VP55 and oligo UU-(dC)25-U. VP55 reactivity indicates that it has free thiols.
Lower panel: Subsequent Coomassie stain of the same gel (showing that each lane contains equivalent amounts of F293 protein). The migration
positions of protein standards are indicated to the right.
(D–F) Thiol occlusion assay data. Plots show relative fluorescence intensity versus time of reaction with Cy3-maleimide for 15 of the 16 VP39
single-cysteine mutants either alone (), in the presence of VP55 (binary complex, ), or in the presence of both VP55 and oligo UU-(dC)25-U
(ternary complex, ). Y77C could not be tested because its reactivity with Cy3-maleimide (B) was insufficient for detection in the timecourse
assay. Ordinate: Fluorescence intensity, as a proportion of the peak intensity observed for the VP39 mutant alone, converted to percent. All
assays were performed in duplicate: mean values from duplicate experiments are shown, error bars indicate the individual values. (D) Mutants
whose thiols were not occluded after complex formation. (E) Mutants whose thiols were considered to be partially occluded after complex
formation, insofar as relative fluorescence intensity was diminished but nonetheless 25% of that of the uncomplexed mutant by the end of
the experiment (upper time scale applies to upper two plots, lower time scale applies to lower plot). (F) Mutants whose thiols were considered
to be occluded after complex formation insofar as relative fluorescence intensity was 	25% of that of the uncomplexed mutant by the end
of the experiment.
versions of the two mutants were unable to form a ter- surface in the vicinity of amino acids 29 and 71, to a
distance of between 14 and 25 A˚.nary complex-specific (i.e., VP55-enhanced) photo-
crosslink with the oligo (Figures 2B and 2C). Although A model for the overall topography of VP39, as deduced
from the above experiments, is shown in Figure 6.we cannot discount the possibility that AET-photocross-
linkable groups are absent in the relevant region of the
oligo, we consider this unlikely because of the relatively Discussion
nonspecific photocrosslinking characteristics of AET’s
reactive aryl azide moiety [20]. Instead, the data may Using various thiol-specific probes, we have charted the
area above the surface of VP39 within the VP39-VP55-be resolved by considering the differences in “reach”
of AET and FeBABE (14 A˚ and 22 A˚ from the cysteine nucleic acid ternary complex and thereby gained insight
into the physical topography of the ternary complex.sulfur, respectively; i.e., 17 A˚ and 25 A˚, respectively,
from the carbon). We therefore consider it possible Figure 6 summarizes the findings.
Two closely apposed regions were previously impli-that the oligonucleotide “peels away” from the VP39
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Figure 5. Chemical Nuclease Assay
The figure shows products after incubation of 32P end-labeled oligo UU-(dC)25-U with either no protein (“”), VP39 cysteine-minus mutant
(“Cys”) or VP39 single-cysteine mutants E29C and P71C. “FeBABE” denotes use of derivatized protein; “A&P” denotes presence of ascorbate
and peroxide. Distances of cleavage sites from the oligo 3 end are indicated to the left of the two storage phosphorgrams. The plots to the
right of each of the two panels show quantitation of the E29C (red) and P71C (blue) gel lanes, after subtraction of the corresponding values
for the Cys gel lane values from each. As an indication of significance, the average signal for all single-cysteine mutants other than E29C
and P71C (gel data not shown) was also subjected to subtraction of the Cys gel lane data, and the resulting values also plotted (black).
Data with derivatized versions of the remaining fourteen single-cysteine mutants were negative in this assay (i.e., resembled the Cys control,
data not shown). For mutant Q183C, this may have been due to low reactivity with FeBABE (data not shown). (A) 5 end-labeled oligo; (B) 3
end-labeled oligo. In (B), RNase A partial (almost complete) cleavage products (second lane) were coelectrophoresed as fragment size-
markers.
cated in VP39-VP55 dimerization contacts through a Y189C, E217C, K126C) being VP55 photocrosslinkable,
they were not occluded from small-molecule derivatiza-combination of mutagenesis, protease footprinting, and
preliminary site-specific photocrosslinking experiments tion (Figure 6A).
We observed site-specific photocrosslinking of VP39[12]. The two regions (on VP39’s “reverse” face) were
centered on the region around R55/C272, and the region to both VP55 and the complexed oligonucleotide oc-
curring in a “stripe” running across one side of VP39around R107. Both of these two regions are encom-
passed by the portion of the yellow patch visible in (colored brown in Figures 3B and 6B). This stripe seems
to indicate the path of binding of the polyadenylylation-Figures 3A and 3B and Figures 6A and 6B. Not only
did the four single-cysteine mutants within this region specific oligonucleotide within the ternary complex. This
previously uncharacterized RNA binding site, which pre-(R55C, Y83C, R107C, C272) all support cysteine-depen-
dent photocrosslinks with VP55 (Figure 2A; Table 1), sumably acts exclusively in VP39’s mRNA 3 end forma-
tion function, is entirely distinct from the site of bindingbut their thiols were also occluded by dimerization with
VP55, with three of them being strongly occluded (Fig- of the capped mRNA 5 end. The latter is already known
to bind VP39’s “front” face (Figures 3C and 6C), as de-ures 4E and 4F; Table 1). This reinforces the notion that
this part of the VP39 surface is sequestered within the duced from the X-ray crystal structure of the VP39-
capped RNA complex [9]. The possession by VP39 ofdimerization interface. It is possible that the region ex-
tends upwards to the side chain of F265, insofar as the distinct RNA binding sites for the mRNA 5 and 3 ends is
consistent with previous biochemical studies indicatingF265C thiol is strongly occluded by VP55 (Figure 4F;
Table 1). However, the F265C thiol did not support pho- the presence of more than one RNA binding site on the
VP39 surface [14]. Moreover, the newly characterizedtocrosslinking, presumably due to the absence of a
crosslinkable group or effects of the AET photocross- site encompasses a residue (R107) that is known to form
a strong zero-length photocrosslink with the down-linker on VP55. The subunit interface apparently “opens
up” in the region adjacent to (beneath) the R55C, Y83C, stream rU of the (rU)2-N25-rU heterodimer binding motif
within the standard 50mer oligonucleotide, after substi-R107C, C272 dimerization “patch.” Thus, despite the
thiols in the adjacent region (i.e., those of mutants tuting this rU with the photosensitive nucleoside 4SrU
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Figure 6. Leftward Rotations of the VP39 Surface Summarizing all the Topographical Data Elucidated Herein and Summarized in Table 1
The overall representation and yellow and brown surface atoms are colored according to Figure 3. In addition, side chains whose cysteine
substitution provided VP55-occludable (or VP55 oligo-occludable) thiols are colored purple, side chains whose cysteine substitution provided
nonoccludable thiols are colored green, and those whose substitution provided partially occludable thiols are colored light blue (according
to the data of Figure 4, panels D - F). The Y77 side chain is not colored because it was insufficiently reactive with cy3-maleimide to be
subjected to the thiol-occlusion assay (see text). Although the unique thiols of mutants Y83C, R107C, and F293C are colored purple, i.e.,
considered essentially unreactive, they showed a very slight yet reproducible reactivity, which decreased slightly in the presence of oligo
(Figure 4F). This is consistent with an occlusional effect of oligo binding (see Discussion). The approximate position of the bound oligo is
shown as a blue ladder. Although an outward arrow marks one end of the bound oligo segment, the 5–3 polarity of the bound oligo is
unknown and therefore is not indicated. Currently, we cannot exclude an alternative model for oligo binding in which it loops over the top of
VP39 instead of under the bottom as indicated (see Discussion). Since the role of the 3D structures is to indicate topological considerations
alone, the variability in crosslinking efficiency that is apparent in Figure 2 is not indicated in the figure.
followed by ternary complex formation and photoirradia- On VP39’s front face, to which the capped mRNA
5 end binds (i.e., to the righthand side of the newlytion [13]. The identification of a larger portion of this
RNA binding site (herein) greatly extends the previous characterized RNA binding site) VP39 and VP55 also
photocrosslink to one another within the ternary com-photocrosslinking data. At the “top” of the newly charac-
terized RNA binding site, thiols are only partially oc- plex (yellow patch in Figures 3C and 6C). However, thiols
are not occluded on the front face (Figure 6C), in contrastcluded in the VP55-VP39 binary complex and the VP55-
VP39-oligo ternary complex (light blue side chains in to the reverse face (above). This would indicate that the
dimerization interface does not entirely “enclose” theFigures 6B and 6C), indicating an opening-up of the RNA
binding site in this region. bound oligonucleotide within a channel running between
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the two subunits. Instead, the oligo would appear to run the “wrapping” of the oligo under the bottom (or over
the top) of VP39 and its exit from the front surface maywithin a deep cleft close to the subunit interface. The
unique thiols of mutants Y83C, R107C, and F293C, al- account for the 10 nt additional spacing between the
two rU-containing portions of the oligonucleotide motifthough almost completely occluded from small mole-
cule reactivity, appear to be reproducibly more occluded in the presence of VP39. In the absence of the VP39
subunit, the segment of RNA between the downstreamin the presence of the model heterodimer binding oligo-
nucleotide ligand than in its absence (Figure 4F). This rU and the upstream (rU)2 would no longer be obliged to
wrap around VP39, but might instead remain physicallycontrasts markedly with the behavior of thiols located
within the dimerization interface (namely, the thiols of linear after VP55-RNA interaction, leading to the reduced
intervening distance between the downstream rU andmutants R55C and F265C), which were completely unre-
active in either the absence or presence of oligo (Figure the upstream (rU)2.
4F). Interestingly, the side chains of the former three
residues (Y83C, R107C, and F293C) lie precisely in the Significance
projected path of the oligonucleotide at the protein sur-
face (Figure 6B), i.e., within the proposed intersubunit In this paper, by assaying chemical reporters attached
cleft containing the newly characterized RNA binding to the unique thiols of a coherent library of single-
site (Figure 6B). These are the three thiols that would cysteine mutants, we have probed the space immedi-
be expected, according to the cleft model, to be the ately above virtually the entire surface of the vaccinia
most sensitive to the presence of oligonucleotide. Fur- virus-encoded RNA-modifying protein VP39 (a PAP
ther support for the cleft model comes from previous processivity factor), after assembly of the latter into a
photocrosslinking studies [15] in which an azidophenz- ternary complex with the PAP and an oligonucleotide
cyl bromide photocrosslinker was attached at various ligand. In doing so, we have located a previously un-
backbone phosphates to a set of oligonucleotides (each known RNA binding site on the protein surface. To our
via a unique phosphorothioate), followed by ternary knowledge, an RNA binding site has not previously
complex formation and photoirradiation. This study been identified and characterized in this manner. It’s
showed a node of protein photocrosslinking for APB- characteristics (i.e., apparently deep cleft at the inter-
attachment points lying between positions –11 and –21 face with the vaccinia virus PAP), are consistent with
in the oligonucleotide [15]. Since the nodes of photo- VP39’s role in conferring processivity to the PAP.
crosslinking were superimposable for the two subunits,
it was surmised that this portion of the oligonucleotide Experimental Procedures
was bound close to the dimerization interface [15], sup-
Materialsporting the current cleft model.
VP55 was expressed from recombinant baculovirus-infected HighIn our conceptual model of the topology of the VP55-
Five insect cells and purified as described [12]. Oligonucleotides
VP39-standard 3 end 50mer oligonucleotide ternary were synthesized using a Model 392 DNA/RNA synthesizer (Applied
complex ([15], see also Introduction), approximately the Biosystems) using reagents manufactured by Cruachem. All syn-
thetic oligonucleotides were purified by urea-PAGE before use. The3 half of the oligonucleotide [containing the down-
sequence of the chimeric 50mer oligonucleotide referred to here asstream rU of the (rU)2-N25-rU heterodimer binding motif]
UU-(dC)25-U [13] is (dC)13-(rU)2-(dC)25-rU-(dC)9-rC.interacts with both subunits of the VP39-VP55 hetero-
dimer, while the 5 portion [containing the upstream (rU)2
Mutagenesis, Expression, and Purification of VP39portion of the motif] contacts the VP55 subunit alone.
VP39 point mutants were prepared using the chameleon double-
The spacing between the two rU-containing patches of stranded site directed mutagenesis kit (Stratagene) as described
the heterodimer binding motif are 10 nt greater than in [12]. The mutagenesis template for all mutants was the plasmid
encoding mutant C178S/C272S as a fusion to the C terminus ofthe (rU)2-N15-rU motif which binds monomeric VP55. By
glutathione S-transferase [2]. Proteins were expressed as describeddefault, this is due to the presence of VP39. The newly
[12]. Briefly, 500–6,000 ml cultures of expression plasmid-trans-characterized RNA binding site indicates a physical path
formed E. coli strain HB101 were grown in superbroth to saturationfor the 3 portion of the heterodimer binding motif-con-
at room temperature, induced with IPTG for 2.5 hr at room tempera-
taining oligonucleotide (Figure 6). How do our data ac- ture, purified over glutathione-agarose, cleaved with thrombin, and
count for the increased distance between the two rU then purified over heparin-agarose as described [12], except that
portions of the motif in the presence of the VP39 sub- the heparin-agarose column buffer contained 1 mM EDTA in place
of 2-mercaptoethanol. Peak fractions from the heparin-agarose col-unit? The data of Figure 5 indicate that FeBABE-deriva-
umn were quantitated by densitometry of Coomassie-stained SDS-tized mutants E29C and P71C cleave the oligonucleotide
PAGE gels (sometimes after ultrafiltration to concentrate the protein)between positions –17 and –28, providing a tentative
as described [11].
distance constraint for this portion of the bound oligo, After purification, all proteins were tested for their ability to conju-
namely 14 A˚–25 A˚ above a portion of the VP39 front gate with AET. Those which were unable to do so or did so only
surface (containing residues E29 and P71). In the context weakly were incubated for 1 hr with 1.6 mM dithiothreitol followed
by four sequential steps of spin gel-filtration chromatograhy (Mac-of such a constraint, the oligonucleotide may track
rospin P-6 columns, The Nest Group) after first equilibrating spinthrough the newly characterized RNA binding site, under
columns in 10 mM HEPES-NaOH (pH 8.0), 10% (v/v) glycerol, 25the bottom of VP39 (as oriented in Figure 6), then away
mM NaCl, 1 mM EDTA, 0.01% (v/v) Nonidet P-40 (buffer A).from VP39’s front face which contains the unique thiols
of mutants E29C and P71C. Currently, we cannot ex- 32P End-Labeling of Oligonucleotides
clude an alternative model of oligo binding that might Oligonucleotides were 5 end-labeled with 32P using T4 polynucleo-
also account for the data, in which it loops over the top tide kinase as described [13]. Oligonucleotides were 3 end-labeled
using [-32P]cordycepin triphosphate, VP55, and VP39, as describedof VP39 instead of under the bottom. We suggest that
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[21, 22]. After completion of all oligonucleotide-labeling procedures, end-labeled oligo UU-(dC)25-U were mixed in 4 
l of buffer B and
incubated at room temperature for 1 hr. Cleavage reactions wereoligonucleotides were sodium acetate/ethanol precipitated and re-
dissolved in DEPC-treated water. initiated by the addition of 0.5 
l of 50 mM ascorbate (free acid [pH
7.0]) and 0.5 
l of 5% (v/v) hydrogen peroxide, followed by incuba-
tion at room temperature for 15 min. Postcleavage samples wereEMSA
ethanol precipitated, redissolved in water, supplemented with anThe EMSA was performed as described [21]. Briefly, binding reac-
equal volume of formamide, and subjected to urea-PAGE (15% T,tions contained buffer A and were 0.25 
M in 32P-labeled oligonucle-
5% C). After electrophoresis, gels were dried under vacuum andotide and 0.2 
M in each protein, in a total volume of 10 
l. Mixtures
imaged using a PhoshorImager (Molecular Dynamics). Lines drawnwere incubated at room temperature for 15 min then applied to
through gel lanes were quantitated using ImageQuant software. Thepre-electrophoresed 8% (w/v) polyacrylamide/0.5 TBE gels and
resulting data were transfered to a spreadsheet for alignment ofelectrophoresed at 10 V/cm for 2.5 hr. Gels were imaged using a
data from the different lanes and data subtraction.PhosphorImager (Molecular Dynamics).
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